Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035589036> ?p ?o ?g. }
- W3035589036 endingPage "112989" @default.
- W3035589036 startingPage "112989" @default.
- W3035589036 abstract "Lei-gong-gen formula granule (LFG) is a folk prescription derived from Zhuang nationality, the largest ethnic minority among the 56 nationalities in China. It is composed of three herbs, namely Centella asiatica (L.) Urb., Eclipta prostrata (L.) L., Smilax glabra Roxb. It has been widely used as health protection tea for many years to prevent cardiovascular and cerebrovascular diseases such as hyperlipidemia and hypertension. This study validated the lipid-lowering effect of LFG in a hyperlipidemia rat model. Then we employed network pharmacology and molecular biological approach to identify the active ingredients of LFG, corresponding targets, and its anti-hyperlipidemia mechanisms. Hyperlipidemia rat model was established by feeding male Sprague-Dawley rats with high-fat diet for two weeks. LFG (two doses of 10 and 20 g/kg) was administered orally to hyperlipidemia rat model for 4 weeks, twice per day. Serum levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) were monitored in rats pre and post-treatment. Hematoxylin-eosin staining was applied to observe the pathology and lipid accumulation of liver. We then performed network pharmacology analysis to predict the ingredients, their associated targets, and hyperlipidemia associated targets. Pathway analysis with significant genes was carried out using KEGG pathway. These genes and proteins intersectioned between compound targets and hyperlipidemia targets were further verified with samples from hyperlipidemia rats treated with LFG using Real-time RT-PCR and Western Blot. LFG attenuated hyperlipidemia in rat model, and this was characterized with decreased serum levels of TC, LDL-C, liver wet weight, and liver index. LFG alleviated the hepatic steatosis in hyperlipidemia rats. Network pharmacology analysis identified 53 bioactive ingredients from LFG formula (three herbs), which link to 765 potential targets. 53 hyperlipidemia associated genes were retrieved from public databases. There were 10 common genes between ingredients-targets and hyperlipidemia associated genes, which linked to 20 bioactive ingredients. Among these 10 genes, 3 of them were validated to be involved in LFG's anti-hyperlipidemia effect using Real-time RT-PCR, namely ADRB2 encoding beta-2 adrenergic receptor, NOS3 encoding nitric oxide synthase 3, LDLR encoding low-density lipoprotein receptor. The cGMP-PKG signaling pathway was enriched for hyperlipidemia after pharmacology network analysis with ADRB2, NOS3, and LDLR. Interestingly, expression of cGMP-dependent protein kinase (PKG) was downregulated in hyperlipidemia rat after LFG treatment. Molecular docking study further supported that ferulic acid, histidine, p-hydroxybenzoic acid, and linalool were potential active ingredients for LFG's anti-hyperlipidemia effect. LC-MS/MS analysis confirmed that ferulic acid and p-hydroxybenzoic acid were active ingredients of LFG. LFG exhibited the lipid-lowering effect, which might be attributed to downregulating ADRB2 and NOS3, and upregulating LDLR through the cGMP-PKG signaling pathway in hyperlipidemia rat. Ferulic acid and p-hydroxybenzoic acid might be the underlying active ingredients which affect the potential targets for their anti-hyperlipidemia effect." @default.
- W3035589036 created "2020-06-19" @default.
- W3035589036 creator A5006175344 @default.
- W3035589036 creator A5007861182 @default.
- W3035589036 creator A5009612843 @default.
- W3035589036 creator A5018614010 @default.
- W3035589036 creator A5025826723 @default.
- W3035589036 creator A5041058861 @default.
- W3035589036 creator A5043521908 @default.
- W3035589036 creator A5052490612 @default.
- W3035589036 creator A5054454797 @default.
- W3035589036 creator A5059144152 @default.
- W3035589036 creator A5073007372 @default.
- W3035589036 creator A5086536116 @default.
- W3035589036 creator A5086827787 @default.
- W3035589036 date "2020-10-01" @default.
- W3035589036 modified "2023-10-07" @default.
- W3035589036 title "Lei-gong-gen formula granule attenuates hyperlipidemia in rats via cGMP-PKG signaling pathway" @default.
- W3035589036 cites W1537873582 @default.
- W3035589036 cites W1546031868 @default.
- W3035589036 cites W184580896 @default.
- W3035589036 cites W1878299089 @default.
- W3035589036 cites W1964214096 @default.
- W3035589036 cites W1967488185 @default.
- W3035589036 cites W1975480667 @default.
- W3035589036 cites W1976886448 @default.
- W3035589036 cites W1987626083 @default.
- W3035589036 cites W1989156168 @default.
- W3035589036 cites W1997023449 @default.
- W3035589036 cites W2000502569 @default.
- W3035589036 cites W2009554185 @default.
- W3035589036 cites W2015310731 @default.
- W3035589036 cites W2015796894 @default.
- W3035589036 cites W2025674081 @default.
- W3035589036 cites W2033591223 @default.
- W3035589036 cites W2038762279 @default.
- W3035589036 cites W2039789335 @default.
- W3035589036 cites W2043750435 @default.
- W3035589036 cites W2044521785 @default.
- W3035589036 cites W2050121195 @default.
- W3035589036 cites W2057000237 @default.
- W3035589036 cites W2069677629 @default.
- W3035589036 cites W2070880994 @default.
- W3035589036 cites W2072934005 @default.
- W3035589036 cites W2074134185 @default.
- W3035589036 cites W2079836777 @default.
- W3035589036 cites W2099373822 @default.
- W3035589036 cites W2105461199 @default.
- W3035589036 cites W2107277218 @default.
- W3035589036 cites W2142453998 @default.
- W3035589036 cites W2151155970 @default.
- W3035589036 cites W2170645399 @default.
- W3035589036 cites W2324986020 @default.
- W3035589036 cites W2525995766 @default.
- W3035589036 cites W2545514195 @default.
- W3035589036 cites W2591757996 @default.
- W3035589036 cites W2625812219 @default.
- W3035589036 cites W2737811084 @default.
- W3035589036 cites W2769307592 @default.
- W3035589036 cites W2787367879 @default.
- W3035589036 cites W3127809699 @default.
- W3035589036 cites W47796 @default.
- W3035589036 doi "https://doi.org/10.1016/j.jep.2020.112989" @default.
- W3035589036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32526339" @default.
- W3035589036 hasPublicationYear "2020" @default.
- W3035589036 type Work @default.
- W3035589036 sameAs 3035589036 @default.
- W3035589036 citedByCount "17" @default.
- W3035589036 countsByYear W30355890362021 @default.
- W3035589036 countsByYear W30355890362022 @default.
- W3035589036 countsByYear W30355890362023 @default.
- W3035589036 crossrefType "journal-article" @default.
- W3035589036 hasAuthorship W3035589036A5006175344 @default.
- W3035589036 hasAuthorship W3035589036A5007861182 @default.
- W3035589036 hasAuthorship W3035589036A5009612843 @default.
- W3035589036 hasAuthorship W3035589036A5018614010 @default.
- W3035589036 hasAuthorship W3035589036A5025826723 @default.
- W3035589036 hasAuthorship W3035589036A5041058861 @default.
- W3035589036 hasAuthorship W3035589036A5043521908 @default.
- W3035589036 hasAuthorship W3035589036A5052490612 @default.
- W3035589036 hasAuthorship W3035589036A5054454797 @default.
- W3035589036 hasAuthorship W3035589036A5059144152 @default.
- W3035589036 hasAuthorship W3035589036A5073007372 @default.
- W3035589036 hasAuthorship W3035589036A5086536116 @default.
- W3035589036 hasAuthorship W3035589036A5086827787 @default.
- W3035589036 hasConcept C104317684 @default.
- W3035589036 hasConcept C134018914 @default.
- W3035589036 hasConcept C185592680 @default.
- W3035589036 hasConcept C2776415932 @default.
- W3035589036 hasConcept C2778163477 @default.
- W3035589036 hasConcept C2779091943 @default.
- W3035589036 hasConcept C55493867 @default.
- W3035589036 hasConcept C555293320 @default.
- W3035589036 hasConcept C556039675 @default.
- W3035589036 hasConcept C71924100 @default.
- W3035589036 hasConcept C98274493 @default.
- W3035589036 hasConceptScore W3035589036C104317684 @default.
- W3035589036 hasConceptScore W3035589036C134018914 @default.